Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Gastric or EGJ Cancer × Ramucirumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 36 Carcinoma, Non-Small-Cell Lung 30 Neoplasms 10 Neoplasm Metastasis 9 Lung Neoplasms 9 Adenocarcinoma 9 Colorectal Neoplasms 8 Esophageal Neoplasms 7 Carcinoma, Hepatocellular 7 Colonic Neoplasms 5 Carcinoma, Renal Cell 5 Breast Neoplasms 5 Adenocarcinoma Of Esophagus 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Rectal Neoplasms 3 Melanoma 3 Liver Neoplasms 3 Carcinoma, Transitional Cell 3 Biliary Tract Neoplasms 3 Ureteral Neoplasms 2 Thymoma 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumors 2 Sarcoma 2 Recurrence 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Non-small Cell Lung Cancer Metastatic 2 Malignant Solid Tumor 2

Interventions

Ramucirumab 1 Paclitaxel 1 IFL protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03081143 2024-12-12

RAMIRIS

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2/3 Active not recruiting

Gastrointestinal

Advanced Gastric or EGJ Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡